Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 17 November 2026
- Last conf. stmt
- 3 November 2025
Ldpath Limited
- Incorporated
- 24 November 2017 (8 years)
- Industry
- Research and experimental development on biotechnology (72110) Other business support service activities n.e.c. (82990)
- Directors
- Jay Charles Lecoque
- Owned by
- Accounts type
- Full
- Region
- East Midlands
- Address
- 1 Orchard PlaceNottingham Business ParkNottinghamNG8 6PX
Charges
- Total
- 3
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 2
Officers 2 active
Officer details are public data from the Companies House register.
Director · Appointed 27 September 2023
British
Born August 1973 (53)
Lecoque, Jay Charles
Director · Appointed 8 March 2022
American
Born November 1962
Officer history (5 former)
27 September 2023
27 September 2023
26 September 2022
4 May 2022
8 March 2022
Appointed Lecoque, Jay Charles as Director
8 March 2022
8 March 2022
Resigned Aljefri, Khadija, Ms. as Director
8 March 2022
Resigned Lallie, Sanjit Singh as Director
8 March 2022
Resigned Robson, Alistair, Dr. as Director
24 November 2017
Appointed Aljefri, Khadija, Ms. as Director
24 November 2017
Appointed Lallie, Sanjit Singh as Director
24 November 2017
Appointed Robson, Alistair, Dr. as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 8 March 2022
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 00079136
Former controllers (3)
8 March 2022
Ceased Khadija Aljefri — Owns 75–100% of shares
8 March 2022
Ceased Sanjit Singh Lallie — Has significant influence or control
8 March 2022
Ceased Alistair Robson — Owns 50–75% of shares
Group structure 11 companies
Ownership group derived from the Companies House PSC register
Source Bioscience Limited Owns 75–100% of shares
Cryobank Guarantor Limited Owns 75–100% of shares
Fairfield Imaging Limited Owns 75–100% of shares
Ldpath Limited This company Owns 75–100% of shares
Select Pharma Laboratories Ltd. Owns 75–100% of shares
Source Bioscience (Orchard Place) Limited Owns 75–100% of shares
Source Bioscience UK Limited Owns 75–100% of shares
Source Genomics Limited Owns 75–100% of shares
Cambridge Clinical Laboratories Ltd Owns 75–100% of shares
Source Bioscience Nominees Limited Owns 75–100% of shares
Financials
Figures from 2022 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £431,465
- up £35,309 (9%)
- Cash
- £425,141
- up £51,097 (14%)
- Employees
- 24
- up 9 (60%)
- Debt Ratio
- 88%
- Current Ratio
- 1.1x
Trend
Net Assets
Balance sheet detail
| 2022 | 2020 | |
|---|---|---|
| Fixed Assets | £1,511,851 | £163,056 |
| Current Assets | £1,986,830 | £1,574,880 |
| Debtors | £1,521,818 | £1,101,165 |
| Cash | £425,141 | £473,715 |
| Creditors (< 1 year) | £1,825,693 | £1,230,953 |
| Creditors (> 1 year) | £1,017,314 | £19,148 |
| Net Current Assets | £161,137 | £343,927 |
| Net Assets | £431,465 | £487,835 |
| Shareholder Funds | £431,465 | £487,835 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 31 July 2026 | Full accounts | 31 December 2025 | ||
| 2 June 2026 | Satisfaction of a charge in full | |||
| 28 May 2026 | Registration of a charge | |||
| 3 November 2025 | Confirmation statement with updates | 3 November 2025 | 5 | |
| 6 August 2025 | Accounts for a small company | 31 December 2024 | 14 |
Some other companies at this address
Other companies in this industry
Newcastle Upon Tyne
Edinburgh
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →